Arvinas Inc
NASDAQ:ARVN 12:35:49 PM EDT
| Market Cap (Intraday) | 3.68B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $77.20 |
| 50-Day MA | $80.08 |
| 200-Day MA | $42.16 |
Arvinas, Inc. Stock, NASDAQ:ARVN
5 Science Park, 395 Winchester Avenue, New Haven, Connecticut 06511
United States of America
Phone: +1.203.535.1456
Number of Employees: 133
Description
Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110 and ARV-471. The company was founded in February 2013 and is headquartered in New Haven, CT.